To cure myeloma by fostering research, education and excellence in clinical care worldwide.

The International Myeloma Society (IMS) is proud to announce webIMarS, a new webinar series co-hosted in partnership with local hematology societies. These 90-minute webinars on Relapsed Refractory Multiple Myeloma will be led by local faculty and are designed for regional audiences. The goal of this series is to share updated knowledge in diagnosis, monitoring, and treatment of Plasma Cell malignancies with a focus on the local practice patterns.

On February 12, 2025 the IMS and Myeloma Australia will co-host a 90-minute complimentary webinar for healthcare professionals who actively treat patients with multiple myeloma in Australia.

Program

The International Myeloma Society (IMS) is proud to announce webIMarS, a new webinar series co-hosted in partnership with local hematology societies. These 90-minute webinars on Relapsed Refractory Multiple Myeloma will be led by local faculty and are designed for regional audiences. The goal of this series is to share updated knowledge in diagnosis, monitoring, and treatment of Plasma Cell malignancies with a focus on the local practice patterns.

On February 19, 2025 the IMS and the Japanese Society of Myeloma will co-host a 90-minute complimentary webinar for healthcare professionals who actively treat patients with multiple myeloma in Australia.

Program

Join us for a dynamic educational workshop on the diagnosis, treatment, and monitoring of plasma cell malignancies, including current practices and opportunities for improvement. This workshop will include lectures plus roundtable discussions around hot and controversial topics, featuring point-counterpoint conversations between invited speakers and local hematologists based on both challenging questions and clinical cases.

IMS is pleased to announce that the 6th Annual Immune Effector Cell Therapies in Multiple Myeloma Workshop will take place from March 28-29, 2025 in Boston, MA.

More details will be available soon! 

Join us for a dynamic educational workshop on the diagnosis, treatment, and monitoring of plasma cell malignancies, including current practices and opportunities for improvement. This workshop will include lectures plus roundtable discussions around hot and controversial topics, featuring point-counterpoint conversations between invited speakers and local hematologists based on both challenging questions and clinical cases.

Mark your calendars for the 22nd IMS Annual Meeting in Toronto, Canada.

The International Myeloma Society Meeting is the defining annual meeting in myeloma with a focus on both the basic, preclinical and the clinical aspects.

The International Myeloma Society Meeting is the defining annual meeting in myeloma with a focus on both the basic, preclinical and the clinical aspects.

More details about this meeting will be shared soon.